Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
Status:
Recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
Vi-DT Typhoid vaccine is a novel vaccine. This study will be done to know the long-term
protection and persistent antibody by measured the antibody titer after 2,3,4 and 5 years
after immunization.